Recent insights into Clostridium perfringens beta-toxin

Toxins

Volumn 7, Issue 2, 2015, Pages 396-406

  Nagahama, Masahiro ^a   Ochi, Sadayuki ^b   Oda, Masataka ^c   Miyamoto, Kazuaki ^a   Takehara, Masaya ^a   Kobayashi, Keiko ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Beta toxin; Clostridium perfringens; Necrotizing enterocolitis; Pore forming toxin

Indexed keywords

CLOSTRIDIUM PERFRINGENS TYPE C VACCINE; CLOSTRIDIUM TOXIN; MITOGEN ACTIVATED PROTEIN KINASE; PENICILLIN DERIVATIVE; PERFRINGOLYSIN O; UNCLASSIFIED DRUG; BACTERIAL TOXIN; CPB PROTEIN, CLOSTRIDIUM PERFRINGENS;

BACTERIAL CHROMOSOME; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CAPILLARY ENDOTHELIAL CELL; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS INFECTION; CLOSTRIDIUM PERFRINGENS TYPE B; CLOSTRIDIUM PERFRINGENS TYPE C INFECTION; CYTOTOXICITY; ENTEROTOXEMIA; GENE EXPRESSION; INTESTINE VILLUS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PATHOGENESIS; PIGLET; QUORUM SENSING; RABBIT; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION; VACCINATION; ANIMAL; CHEMICALLY INDUCED; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; VIRULENCE;

CLOSTRIDIUM PERFRINGENS; ORYCTOLAGUS CUNICULUS;

ANIMALS; BACTERIAL TOXINS; CLOSTRIDIUM PERFRINGENS; ENTEROCOLITIS, NECROTIZING; ENTEROTOXEMIA; HUMANS; VIRULENCE;

EID: 84923198091     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins7020396     Document Type: Review

References (63)

1. McDonel, J.L. Pharmacology of Bacterial Toxins; Pergamon Press: New York, NY, USA, 1986; pp. 477–517.
2. Sakurai, J. Toxins of Clostridium perfringens. Rev. Med. Microbiol. 1995, 6, 175–185.
3. Sakurai, J.; Nagahama, M.; Ochi, S. Major toxins of Clostridium perfringens. J. Toxicol. Toxin Rev. 1997, 16, 195–214.
4. Songer, J.G. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 1996, 9, 216–234.
5. Sakurai, J.; Nagahama, M. Clostridium perfringens beta-toxin: Characterization and action. Toxin Rev. 2006, 25, 89–108.
6. Popoff, M.R.; Bouvet, P. Clostridial toxins. Future Microbiol. 2009, 4, 1021–1064.
7. Popoff, M.R. Clostridial pore-forming toxins: Powerful virulence factors. Anaerobe 2014, 30, 220–238.
8. Uzal F.A.; McClane, B.A. Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections. Vet. Microbiol. 2011, 153, 37–43.
9. Ma, M.; Gurjar, A.; Theoret, J.R.; Garcia, J.P.; Beingesser, J.; Freedman, J.C.; Fisher, D.J.; McClane, B.A.; Uzal, F.A. Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops. Infect. Immun. 2014, 82, 2958–2970.
10. Timoney, J.F.; Gillespie, J.H.; Scott, F.W.; Barlough, J.E. Hagan and Bruner’s Microbiology and Infectious Diseases of Domestic Animals; Comstock Publishing Associates: New York, NY, USA, 1988.
11. Fitzgerald, G.R.; Barker, T.; Welter, M.W.; Welter, C.J. Diarrhea in young pigs: Comparing the incidence of the five most common infectious agents. Vet. Med. 1988, 83, 80–86.
12. Johnson, M.W.; Fitzgerald, G.R.; Welter, M.W.; Welter, C.J. The six most common pathogens responsible for diarrhea in newborn pigs. Vet. Med. 1992, 87, 382–386.
13. Griner, L.A.; Bracken, K.F. Clostridium perfringens (type C) in acute hemorrhagic enteritis in calves. J. Am. Vet. Med. Assoc. 1953, 122, 99–102.
14. Griner, L.A.; Johnson, H.W. Clostridium perfringens type C in hemorrhagic enterotoxemia of lambs. J. Am. Vet. Med. Assoc. 1954, 125, 125–127.
15. Gurtner, C.; Popescu, F.; Wyder, M.; Sutter, E.; Zeeh, F.; Frey, J.; von Schubert, C.; Posthaus, H. Rapid cytopathic effects of Clostridium perfringens beta-toxin on porcine endothelial cells. Infect. Immun. 2010, 78, 2966–2973.
16. Popescu, F.; Wyder, M.; Gurtner, C.; Frey, J.; Cooke, R.A.; Greenhill, A.R.; Posthaus, H. Susceptibility of primary human endothelial cells to C. perfringens beta-toxin suggesting similar pathogenesis in human and porcine necrotizing enteritis. Vet. Microbiol. 2011, 153, 173–177.
17. Johnson, S.; Gerding, D.N. Enterotoxemic infections. In The Clostridia: Molecular Biology and Pathogenesis; Rood, J.I., McClane, B.A., Songer, J.G., Titball, R.W., Eds.; Academic Press: London, UK, 1997; pp. 117–140.
18. Ma, M.; Li, J.; McClane, B.A. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany. Infect. Immun. 2012, 80, 4354–4363.
19. Lawrence, G.W.; Lehmann, D.; Anian, G.; Coakley, C.A.; Saleu, G.; Barker, M.J.; Davis, M.W. Impact of active immunization against enteritis necroticans in Papua New Guinea. Lancet 1990, 336, 1165–1167.
20. Murrell, T.G.; Roth, L.; Egerton, J.; Samels, J.; Walker, P.D. Pig-bel: Enteritis necroticans. A study in diagnosis and management. Lancet 1966, 1, 217–222.
21. McClane, B.A.; Uzal, F.A.; Miyakawa, M.F.; Lyerly, D.; Wilkins, T. The Enterotoxic clostridia. In The Prokaryotes; Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.H., Stackebrandt, E., Eds.; Springer: New York, NY, USA, 2004; pp. 698–752.
22. Lee, H.; Bueschel, D.M.; Nesheim, S.R. Enteritis necroticans (Pigbel) in a diabetic child. N. Eng. J. Med. 2000, 342, 1250–1253.
23. Gui, L.; Subramony, C.; Fratkin, J.; Hughson, M.D. Fatal enteritis necroticans (Pigbel) in a diabetic adult. Mod. Pathol. 2002, 15, 66–70.
24. Sobel, J.; Mixter, C.G.; Kolhe, P.; Gupta, A.; Guarner, J.; Zaki, S.; Hoffman, N.A.; Songer, J.G.; Fremont-Smith, M.; Fischer, M. et al. Necrotizing enterocolitis associated with Clostridium perfringens type A in previously healthy North American adults. J. Am. Coll. Surg. 2005, 201, 48–56.
25. Matsuda, T.; Okada, Y.; Tanabe, Y.; Shimizu, Y.; Nagashima, K.; Sakurai, J.; Nagahama, M.; Tanaka, S. Enteritis necroticans “pigbel” in a Japanese diabetic adult. Pathol. Int. 2007, 57, 622–626.
26. Lawrence, G.; Shann, F.; Freestone, D.S.; Walker, P.D. Prevention of necrotizing enteritis in Papua New Guinea by active immunization. Lancet 1979, 1, 227–230.
27. Davis, M.; Lawrence, G.; Shann, F.; Walker, P.D. Longevity of protection by active immunization against necrotising enteritis in Papua New Guinea. Lancet 1982, 2, 389–390.
28. Springer, S.; Selbitz, H.J. The control of necrotic enteritis in sucking piglets by means of a Clostridium perfringens toxoid vaccine. FEMS. Immunol. Med. Microbiol. 1999, 24, 333–336.
29. Milach, A.; de los Santos, J.R.; Turnes, C.G.; Moreira, A.N.; de Assis, R.A.; Salvarani, F.M.; Lobato, F.C.; Conceição, F.R. Production and characterization of Clostridium perfringens recombinant β toxoid. Anaerobe 2012, 18, 363–365.
30. Salvarani, F.M.; Conceição, F.R.; Cunha, C.E.; Moreira, G.M.; Pires, P.S.; Silva, R.O.; Alves, G.G.; Lobato, F.C. Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine. Vaccine 2013, 31, 4152–4155.
31. Bhatia, B.; Solanki, A.K.; Kaushik, H.; Dixit, A.; Garg, L.C. B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: expression, purification and characterization of the chimeric protein. Protein Expr. Purif. 2014, 102, 38–44.
32. Sayeed, S.; Uzal, F.A.; Fisher, D.J.; Saputo, J.; Vidal, J.E.; Chen, Y.; Gupta, P.; Rood, J.I.; McClane, B.A. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol. 2008, 67, 15–30.
33. Uzal, F.A.; Saputo, J.; Sayeed, S.; Vidal, J.E.; Fisher, D.J.; Poon, R.; Adams, V.; Fernandez-Miyakawa, M.E.; Rood, J.I.; McClane, B.A. Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C enterotoxemias. Infect. Immun. 2009, 77, 5291–5299.
34. Vidal, J.E.; McClane, B.A.; Saputo, J.; Parker, J.; Uzal, F.A. Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon. Infect. Immun. 2008, 76, 4396–4404.
35. Ma, M.; Vidal, J.; Saputo, J.; McClane, B.A.; Uzal, F. The VirS/VirR two-component system regulates the anaerobic cytotoxicity, intestinal pathogenicity, and enterotoxemic lethality of Clostridium perfringens type C isolate CN3685. MBio 2011, 2, doi:10.1128/mBio.00338-10.
36. Vidal, J.E.; Ma, M.; Saputo, J.; Garcia, J.; Uzal, F.A.; McClane, B.A. Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685. Mol. Microbiol. 2012, 83, 179–194.
37. Garcia, J.P.; Beingesser, J.; Fisher, D.J.; Sayeed, S.; McClane, B.A.; Posthaus, H.; Uzal, F.A. The effect of Clostridium perfringens type C strain CN3685 and its isogenic beta toxin null mutant in goats. Vet. Microbiol. 2012, 157, 412–419.
38. Vidal, J.E.; Ohtani, K.; Shimizu, T.; McClane, B.A. Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Cell. Microbiol. 2009, 11, 1306–1328.
39. Miclard, J.; Jäggi, M.; Sutter, E.; Wyder, M.; Grabscheid, B.; Posthaus, H. Clostridium perfringens beta-toxin targets endothelial cells in necrotizing enteritis in piglets. Vet. Microbiol. 2009, 137, 320–325.
40. Schumacher, V.L.; Martel, A.; Pasmans, F.; van Immerseel, F.; Posthaus, H. Endothelial binding of beta toxin to small intestinal mucosal endothelial cells in early stages of experimentally induced Clostridium perfringens type C enteritis in pigs. Vet. Pathol. 2013, 50, 626–629.
41. Miclard, J.; van Baarlen, J.; Wyder, M.; Grabscheid, B.; Posthaus, H. Clostridium perfringens beta-toxin binding to vascular endothelial cells in a human case of enteritis necroticans. J. Med. Microbiol. 2009, 58, 826–828.
42. Gibert, M.; Perelle, S.; Daube, G.; Popoff, M.R. Clostridium spiroforme toxin genes are related to C. perfringens iota toxin genes but have a different genomic localization. Syst. Appl. Microbiol. 1997, 20, 337–347.
43. Katayama, S.; Dupuy, B.; Daube, G.; China, B.; Cole, S.T. Genome mapping of Clostridium perfringens strains with I-CeuI shows many virulence genes to be plasmid-borne. Mol. Gen. Genet. 1996, 251, 720–726.
44. Sayeed, S.; Li, J.; McClane, B.A. Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates. Infect. Immun. 2010, 78, 495–504.
45. Li, J.; Adams, V.; Bannam, T.L.; Miyamoto, K.; Garcia, J.P.; Uzal, F.A.; Rood, J.I.; McClane, B.A. Toxin plasmids of Clostridium perfringens. Microbiol. Mol. Biol. Rev. 2013, 77, 208–233.
46. Gurjar, A.; Li, J.; McClane, B.A. Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect. Immun. 2010, 78, 4860–4869.
47. Sakurai, J.; Fujii, Y.; Matsuura, M. Effect of oxidizing agents and sulfhydryl group reagents on beta toxin from Clostridium perfringens type C. Microbiol. Immunol. 1980, 24, 595–601.
48. Sakurai, J.; Fujii, Y. Purification and characterization of Clostridium perfringens beta toxin. Toxicon 1987, 25, 1301–1310.
49. Hunter, S.E.; Brown, J.E.; Oyston, P.C.; Sakurai, J.; Titball, R.W. Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus. Infect. Immun. 1993, 61, 3958–3965.
50. Geny, B.; Popoff, M.R. Bacterial protein toxins and lipids: Pore formation or toxin entryinto cells. Biol. Cell. 2006, 98, 667–678.
51. Steinthorsdottir, V.; Fridriksdottir, V.; Gunnarsson, E.; Andrésson, O.S. Site-directed mutagenesis of Clostridium perfringens beta-toxin: expression of wild-type and mutant toxins in Bacillus subtilis. FEMS Microbiol. Lett. 1998, 158, 17–23.
52. Sakurai, J.; Fujii, Y.; Nagahama, M. Effect of p-chloromercuribenzoate on Clostridium perfringens beta-toxin. Toxicon. 1992, 30, 323–330.
53. Nagahama, M.; Kihara, A.; Miyawaki, T.; Mukai, M.; Sakaguchi, Y.; Ochi, S.; Sakurai, J. Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity. Biochim. Biophys. Acta 1999, 1454, 97–105.
54. Sakurai, J.; Fujii, Y.; Matsuura, M.; Endo, K. Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Microbiol. Immunol. 1981, 25, 423–432.
55. Sakurai, J.; Fujii, Y.; Dezaki, K.; Endo, K. Effect of Clostridium perfringens beta toxin on blood pressure of rats. Microbiol. Immunol. 1984, 28, 23–31.
56. Nagahama, M.; Morimitsu, S.; Kihara, A.; Akita, M.; Setsu, K.; Sakurai, J. Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation. Br. J. Pharmacol. 2003, 138, 23–30.
57. Nagahama, M.; Kihara, A.; Kintoh, H.; Oda, M.; Sakurai, J. Involvement of tumor necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice. Br. J. Pharmacol. 2008, 153, 1296–1302.
58. Autheman, D.; Wyder, M.; Popoff, M.; D’Herde, K.; Christen, S.; Posthaus, H. Clostridium perfringens beta-toxin induces necrostatin-inhibitable, calpain-dependent necrosis in primary porcine endothelial cells. PLoS One 2013, 8, doi:10.1371/journal.pone.0064644.
59. Steinthorsdottir, V.; Halldórsson, H.; Andrésson, O.S. Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells. Microb. Pathog. 2000, 28, 45–50.
60. Shatursky, O.; Bayles, R.; Rogers, M.; Jost, B.H.; Songer, J.G.; Tweten, R.K. Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect. Immun. 2000, 68, 5546–5551.
61. Tweten, R.K. Clostridium perfringens beta-toxin and Clostridium septicum alpha-toxin: Their mechanisms and possible role in pathogenesis. Vet. Microbiol. 2001, 82, 1–9.
62. Nagahama, M.; Hayashi, S.; Morimitsu, S.; Sakurai, J. Biological activities and pore formation of Clostridium perfringens beta-toxin in HL 60 cells. J. Biol. Chem. 2003, 278, 36934–36941.
63. Nagahama, M.; Shibutani, M.; Seike, S.; Yonezaki, M.; Takagishi, T.; Oda, M.; Kobayashi, K.; Sakurai, J. The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin. Infect. Immun. 2013, 81, 3703–3708.